Telix Pharmaceuticals Ltd - ESG Rating & Company Profile powered by AI
The ESG rating includes seventeen United Nations SDGs including: 'Gender Equality', 'Sustainable Cities & Communities' and 'Peace, Justice & Strong Institutions'. If you work at Telix Pharmaceuticals Ltd and you would like to use your Sustainability rating, please get in touch. The article includes a Q&A section on Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Telix Pharmaceuticals Ltd | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Telix Pharmaceuticals Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd report the average age of the workforce?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd offer flexible work?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd conduct supply chain audits?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose water use targets?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Telix Pharmaceuticals Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Telix Pharmaceuticals Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Telix Pharmaceuticals Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose its waste policy?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose energy use targets?
Sign up for free to unlockDoes Telix Pharmaceuticals Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Telix Pharmaceuticals Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Telix Pharmaceuticals Ltd
These potential risks are based on the size, segment and geographies of the company.
Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company focuses on developing diagnostic and therapeutic products using MTR. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX66-CDx to treat bone marrow conditioning and rare diseases; TLX250, which is in Phase II clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX250-CDx that is in Phase III clinical trials for the diagnosis and treatment of renal (kidney) cancer; TLX591, which is in Phase III clinical trials for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX101 that is in Phase I/II clinical trials and TLX101-CDx for the diagnosis and treatment of glioblastoma (brain cancer); and TLX66, which is in Phase I/IIa clinical trials for the treatment of bone marrow conditioning and rare diseases. The company also develops TLX592, a prostate cancer therapy candidate for targeted alpha therapy; TLX591-Sx, a positron emission tomography (PET) tracer that delivers PET and fluorescent (optical) imaging; and TLX599-CDx, an investigational prostate cancer imaging agent that uses single photon emission computed tomography. It has a strategic license and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited for developing a portfolio of MTR products; scientific and clinical research collaboration with Mauna Kea Technologies; and strategic collaboration agreement with Lightpoint Medical, Ltd. The company was founded in 2015 and is headquartered in North Melbourne, Australia.